Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2010
09/08/2010EP2224910A1 Rinse solution
09/08/2010EP2224909A1 Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds
09/08/2010EP2224906A1 A method for producing adapalene gels
09/08/2010EP2224904A2 Intravesical compositions with valrubicin for the treatment of bladder cancer
09/08/2010EP1901755B1 New pharmaceutical compositions containing hyaluronic acid or its derivatives and collagenase for the topical treatment of wounds, burns and ulcers
09/08/2010EP1735349B1 Method of assessing the risk of ischemic cardiovascular disease using phosphorylcholine conjugates
09/08/2010EP1713468B9 Anthelmintic composition
09/08/2010EP1696960B1 Intranasal administration of glucose-regulating peptides
09/08/2010EP1610820B1 High concentration antibody and protein formulations
09/08/2010EP1478667B1 Anti-human tenascin monoclonal antibody
09/08/2010EP1476171B1 Transportation of nucleic acid substances
09/08/2010EP1429797B1 Diagnosis and treatment of malignant neoplasms
09/08/2010EP1399190B1 Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers
09/08/2010EP1196196B1 Conjugate for mediating cell, compartment or membrane-specific transport of active substances
09/08/2010EP0981373B2 Biofunctional polymers prepared in supercritical fluid
09/08/2010CN1915221B Liposome of alkaloid in vinca, and preparation method
09/08/2010CN1897967B A pharmaceutical composition comprising an active principle and sulphobetaine
09/08/2010CN1878571B Polysaccharide-containing composition and lacrimal fluid layer-stabilizing instillation
09/08/2010CN1853640B Doxycycline hyclate liposome and production thereof
09/08/2010CN1688343B Modified saccharides, conjugates thereof, and their manufacture
09/08/2010CN101827864A Liquid formulation of G-CSF conjugate
09/08/2010CN101827613A Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
09/08/2010CN101827612A Buffer solutionsha ving selective bactericidal activity against gramnegative bacteria and methods of using same
09/08/2010CN101827607A Influenza antigen delivery vectors and constructs
09/08/2010CN101827587A Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof
09/08/2010CN101827583A Peptides that target to tumor blood vessels of lung cancer and applications thereof
09/08/2010CN101827582A Oral composition comprising a cooling agent
09/08/2010CN101827578A Inverted vesicle
09/08/2010CN101827577A Novel compounds prepared by adding an oxetane derivative to an alcohol
09/08/2010CN101824142A Biodegradable butane diacid ester, preparation method and application thereof
09/08/2010CN101824091A G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof
09/08/2010CN101824090A Monoclonal antibody hpam4
09/08/2010CN101824083A C-terminal deletion type p43 protein and application thereof in medicaments for treating tumor
09/08/2010CN101822841A Application of organic amine derivatives as brain-targeting modification group of small-molecule drug
09/08/2010CN101822840A LIGHT-antitumor-antigen antibody for preventing and treating primary and metastatic cancer
09/08/2010CN101822839A Preparation of nanometer structure lipid carrier by using seal oil as liquid-phase substrate and application
09/08/2010CN101822838A Nano-medicament carrier material for target recognition of tumor cell as well as preparation and application thereof
09/08/2010CN101822825A Paste for preventing infection of purulent and exudative skin diseases
09/08/2010CN101822822A Drug composition of pramlintide and preparation method thereof
09/08/2010CN101822820A Stable protein formulations
09/08/2010CN101822817A Compound doxycycline hydrochloride injection for treating intestinal diseases of animals and preparation method thereof
09/08/2010CN101822796A Silver ice buccal tablet, and preparation method and application thereof
09/08/2010CN101822750A Camellia nitidissima tea polyphenols slow release microsphere particle and production method thereof
09/08/2010CN101822741A Oral ulcer healing membrane with traditional Chinese medicine bioadhesive one-way medicine release
09/08/2010CN101822713A Method for preparing pogostemon cablin volatile oil beta-cyclodextrin clathrate compound by ultrasonic method
09/08/2010CN101822706A Gynostemma pellet preparation for preventing subclinical mastitis and preparation method thereof
09/08/2010CN101822701A Poplar flower sustained release tablet for treating livestock and poultry dysentery and enteritis and preparation method thereof
09/08/2010CN101822681A Cefoxitin sodium drug combination
09/08/2010CN101822680A Cefpiramide drug combination
09/08/2010CN101822679A Cefepime hydrochloride combined medicament
09/08/2010CN101822678A Cefamandole nafate combined drug
09/08/2010CN101822673A Iloperidone-containing solid medicinal composition
09/08/2010CN101822671A Rabeprazde composition and preparation method thereof
09/08/2010CN101822665A Ascaridol gastric retention preparation and preparation method thereof
09/08/2010CN101822653A Clindamycin phosphate film agent and preparation method thereof
09/08/2010CN101822652A Vinpocetine transdermal patch and preparation method thereof
09/08/2010CN101822651A Chewable capsule and preparation method thereof
09/08/2010CN101822650A Minocycline hydrochloride sustained release tablet and preparation method thereof
09/08/2010CN101822648A Preparation method and application of nano dobesilate calcium capsule or tablet
09/08/2010CN101822647A Tartaric acid rogridone dispersing tablet and preparation method thereof
09/08/2010CN101822646A Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof
09/08/2010CN101822645A Controlled-release recombinant human bone morphogenic protein-2 poly-L-lactic acid microspheres and preparation method thereof
09/08/2010CN101822644A Micro-balloon injection for pharmaceutical composition of cefmenoxime hydrochloride / anhydrous sodium carbonate
09/08/2010CN101822643A Ligustrazine nanoparticle, preparation method and pharmaceutical application thereof
09/08/2010CN101822642A Peptide modified invisible nano particle loaded with anti-tumor angiogenesis drug and application thereof
09/08/2010CN101822641A K237 polypeptide-modified invisible nanoparticles and application thereof
09/08/2010CN101822640A Sulbenicillin sodium liposome injection
09/08/2010CN101822639A Ancitabine dimyristate acid ester liposome and preparation method thereof
09/08/2010CN101822638A Nano-emulsion of stilbene compound and preparation method thereof
09/08/2010CN101822637A Beta-lactam antibiotics-containing suspension injection
09/08/2010CN101822635A Novel in situ liquid crystal vascular embolization agent
09/08/2010CN101822634A Dihydroquercetin oral solid dispersion preparation as well as preparation method and application thereof
09/08/2010CN101822622A Preparation method and application of nano-citrulline gel
09/08/2010CN101822382A Fruity tea polyphenol buccal tablet and preparation method thereof
09/08/2010CN101518617B Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same
09/08/2010CN101428846B Nano-hollow sphere structured amorphous zinc oxide and method for producing the same
09/08/2010CN101422460B Preparation method of FK506 slow-release film for repairing nerve damage
09/08/2010CN101352365B Positioner for fixing micro organs
09/08/2010CN101336885B Preparation method of microelement nano fibrofelt
09/08/2010CN101317831B Cellulose and plant polyoses capsule
09/08/2010CN101214291B Externally-applied medicine for treating cervical and lumbar diseases without operation
09/08/2010CN101181267B Zolmitriptan tongue tablet
09/08/2010CN101129388B Pharmaceutical composition of compound fat-soluble vitamin and method of preparing the same
09/08/2010CN101129374B Vinflunine pharmaceutical composition and method of producing the same and application of the same
09/08/2010CN101129340B Method of producing nano magnetic polylactic acid composite particle for photodynamic medicament carrier
09/08/2010CN101099735B Wide-spectrum high-efficient microorganism killing agent
09/08/2010CN101090737B Method for stabilizing dementia-resisting medicine
09/08/2010CN101036695B Oil-in-water type nanometer emulsion of elecampane oil and litsea citrata oil and the method for preparing the same
09/08/2010CN101015573B Patrinai villosa dropping pill and its preparing process
09/08/2010CN101015571B Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
09/08/2010CN101011579B Application of cytoplasm-targeting chitosan oligosaccharide-aliphatic acid grafting medicinal-vector colloidal cluster
09/07/2010US7790860 Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids
09/07/2010US7790853 Determination of bone-sialoprotein in bodily fluids for oncological problems
09/07/2010US7790852 Liquid composition of factor VII polypeptides
09/07/2010US7790835 Method of preparing maleimide functionalized polymers
09/07/2010US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability
09/07/2010US7790686 Prevents the aggregation of LHRH antagonists in solutions; bioavailability
09/07/2010US7790680 Hemophilia biodrug recombinant porcine factor 8 formulation with replacement for albumin stabilizer, which may carry risk of prions; surfactant such as polysorbate, calcium chloride, sucrose, sodium chloride, trisodium citrate, and a buffer devoid of amino acids
09/07/2010US7790473 reacting a glycoside with an alkylthio acid to produce a thioester, debenzylidenating the thioester and hydrolyzing the thioester to produce a biofunctional group-thiol (Thomsen-Friedenreich-thiol ), refluxing product thiol with cadmium perchlorate, hydrogen sodium telluride and mercaptoacetic acid
09/07/2010US7790415 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents